Orion’s performance improved compared to the previous period

Orionn, a pharmaceutical company, reported improved results for the October-September period compared to the previous year. The company’s operating profit increased to 92.9 million euros from 40.7 million euros in the same period a year ago, surpassing analyst forecasts.

One of the factors contributing to this improvement was a 30.7 million euro installment related to the transfer of the insurance portfolio of Orion Pension Foundation’s B section. When adjusted for this item, the result still showed improvement from the previous year.

Turnover for the quarter was 321.1 million euros, higher than the estimated 318.9 million euros and the 294.5 million euros from the previous year. Earnings per share also increased, reaching 0.54 euros per share compared to the expected 0.43 euros.

The board of directors proposed a dividend of 1

By Editor

Leave a Reply